104 related articles for article (PubMed ID: 8733681)
1. Granisetron in the prevention of vomiting induced by conditioning for stem cell transplantation: a prospective randomized study.
Okamoto S; Takahashi S; Tanosaki R; Sakamaki H; Onozawa Y; Oh H; Miyawaki S; Kimura Y; Toyama K; Ikeda Y; Asano S
Bone Marrow Transplant; 1996 May; 17(5):679-83. PubMed ID: 8733681
[TBL] [Abstract][Full Text] [Related]
2. Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial.
Walsh T; Morris AK; Holle LM; Callander N; Bradshaw P; Valley AW; Clark G; Freytes CO
Bone Marrow Transplant; 2004 Dec; 34(11):963-8. PubMed ID: 15489869
[TBL] [Abstract][Full Text] [Related]
3. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation.
Fox-Geiman MP; Fisher SG; Kiley K; Fletcher-Gonzalez D; Porter N; Stiff P
Biol Blood Marrow Transplant; 2001; 7(11):596-603. PubMed ID: 11760147
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of granisetron, a 5-HT3 antagonist, in the prevention of nausea and vomiting induced by conditioning for hematopoietic stem cell transplantation].
Hirabayashi N; Goto S; Morishima Y; Sao H; Matsuyama T; Kodera Y; Yamada H; Horibe K; Yano K; Kojima H; Ogura M; Tanimoto M; Morishita Y; Yazaki M; Utsumi M; Nagata K; Kato Y; Naoe T; Saito H
Rinsho Ketsueki; 1998 Jan; 39(1):21-6. PubMed ID: 9492549
[TBL] [Abstract][Full Text] [Related]
5. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
Slabý J; Trnený M; Procházka B; Klener P
Neoplasma; 2000; 47(5):319-22. PubMed ID: 11130251
[TBL] [Abstract][Full Text] [Related]
6. Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation.
Abbott B; Ippoliti C; Bruton J; Neumann J; Whaley R; Champlin R
Bone Marrow Transplant; 1999 Feb; 23(3):265-9. PubMed ID: 10084258
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of granisetron in the prevention of emesis induced by conditioning chemotherapy for allogeneic bone marrow transplantation].
Takeyama H; Miyata Y; Yamamoto Y; Saito M; Yamada H
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2095-9. PubMed ID: 9838912
[TBL] [Abstract][Full Text] [Related]
8. Granisetron plus dexamethasone versus granisetron alone in the prevention of vomiting induced by conditioning for stem cell transplantation: a prospective randomized study.
Matsuoka S; Okamoto S; Watanabe R; Mori T; Nagayama H; Hamano Y; Yokoyama K; Takayama N; Ikeda Y
Int J Hematol; 2003 Jan; 77(1):86-90. PubMed ID: 12568305
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation.
Spitzer TR; Friedman CJ; Bushnell W; Frankel SR; Raschko J
Bone Marrow Transplant; 2000 Jul; 26(2):203-10. PubMed ID: 10918432
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of the use of granisetron, a selective 5-HT3 antagonist, versus a standard anti-emetic regimen of chlorpromazine plus dexamethasone in the treatment of cytostatic-induced emesis. The Granisetron Study Group.
Marty M
Eur J Cancer; 1990; 26 Suppl 1():S28-32. PubMed ID: 2169783
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy.
Burris H; Hesketh P; Cohn J; Moriconi W; Ryan T; Friedman C; Fitts D
Cancer J Sci Am; 1996; 2(2):85-90. PubMed ID: 9166505
[TBL] [Abstract][Full Text] [Related]
12. Granisetron in the prevention of irradiation-induced emesis.
Prentice HG; Cunningham S; Gandhi L; Cunningham J; Collis C; Hamon MD
Bone Marrow Transplant; 1995 Mar; 15(3):445-8. PubMed ID: 7599570
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced nausea and vomiting in acute leukemia and stem cell transplant patients: results of a multicenter, observational study.
López-Jiménez J; Martín-Ballesteros E; Sureda A; Uralburu C; Lorenzo I; del Campo R; Fernández C; Calbacho M; García-Belmonte D; Fernández G
Haematologica; 2006 Jan; 91(1):84-91. PubMed ID: 16434375
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
Chiou TJ; Tzeng WF; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429
[TBL] [Abstract][Full Text] [Related]
15. Tropisetron, ondansetron, and granisetron for control of chemotherapy-induced emesis in Turkish cancer patients: a comparison of efficacy, side-effect profile, and cost.
Abali H; Celik I
Cancer Invest; 2007; 25(3):135-9. PubMed ID: 17530482
[TBL] [Abstract][Full Text] [Related]
16. An all oral antiemetic regimen for patients undergoing high-dose chemotherapy with peripheral blood stem cell transplant.
Frakes LA; Brehm TL; Kosty MP; Miller WE; McMillan RL; Mason J; Meisenberg BR
Bone Marrow Transplant; 1997 Sep; 20(6):473-8. PubMed ID: 9313880
[TBL] [Abstract][Full Text] [Related]
17. Controlling conditioning-related emesis in children undergoing bone marrow transplantation.
Mehta NH; Reed CM; Kuhlman C; Weinstein HJ; Parsons SK
Oncol Nurs Forum; 1997 Oct; 24(9):1539-44. PubMed ID: 9348595
[TBL] [Abstract][Full Text] [Related]
18. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
19. Comparative crossover trial of two intravenous doses of granisetron (1 mg vs 3 mg) + dexamethasone in the prevention of acute cis-platinum-induced emesis.
Martoni A; Piana E; Strocchi E; Angelelli B; Guaraldi M; Zamagni C; Camaggi CM; Pannuti F
Anticancer Res; 1998; 18(4B):2799-803. PubMed ID: 9713464
[TBL] [Abstract][Full Text] [Related]
20. Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapy.
Sigsgaard T; Herrstedt J; Andersen LJ; Havsteen H; Langer SW; Kjaerbøl AG; Lund H; Kjaer M; Dombernowsky P
Br J Cancer; 1999 May; 80(3-4):412-8. PubMed ID: 10408847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
